These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


80 related items for PubMed ID: 5128856

  • 1. Visualization of aldosterone-producing tumors (APT) by scintillation scanning (SS) employing tracer amounts of 131 -iodocholesterol.
    Conn JW, Cohen EL, Lucas CP, Mcdonald WJ, Beierwaltes WH, Anseri AN, Morita R, Bookstein JJ, Herwig KR.
    J Lab Clin Med; 1971 Nov; 78(5):814-5. PubMed ID: 5128856
    [No Abstract] [Full Text] [Related]

  • 2. Location of aldosterone-producing adenomas with 131I-19-iodocholesterol.
    Hogan MJ, McRae J, Schambelan M, Biglieri EG.
    N Engl J Med; 1976 Feb 19; 294(8):410-4. PubMed ID: 1246308
    [Abstract] [Full Text] [Related]

  • 3. 131I-19-iodocholesterol visualization of an adrenal carcinoma without clinical manifestations.
    Bossuyt A, Somers G.
    J Nucl Biol Med; 1975 Feb 19; 19(4):225-7. PubMed ID: 1223256
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Editorial: Solving the adrenal lesion(s) of primary aldosteronism.
    Melby JC.
    N Engl J Med; 1976 Feb 19; 294(8):441-2. PubMed ID: 1246312
    [No Abstract] [Full Text] [Related]

  • 6. Adrenal scintigraphy with 131I-19-iodocholesterol.
    Hoefnagels WH, Claessens RA, Beex LV, Smals AG, Drayer JI, Kazem I, Kloppenborg PW.
    Neth J Med; 1976 Feb 19; 19(6):261-6. PubMed ID: 1004667
    [No Abstract] [Full Text] [Related]

  • 7. Localization of a virilizing adrenal carcinoma by 131I-19-iodocholesterol scintigraphy.
    Barbarino A, Perrelli L, Menini E, De Marinis L, Bonomo L, Pasargiklian E.
    J Nucl Biol Med; 1976 Feb 19; 20(4):172-5. PubMed ID: 1025302
    [No Abstract] [Full Text] [Related]

  • 8. [Scintigraphy using iodine-131-labeled 19-iodocholesterol in the study of adrenal pathology].
    Lacourcière Y, Tremblay RR, Bélanger CG, Bernier JP.
    Union Med Can; 1975 Mar 19; 104(3):395-9. PubMed ID: 1162769
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A new radiotracer for scintigraphy of the adrenal glands: 6-methyl-Se75-selenocholesterol. Its value in comparison with 131-I-19-iodocholesterol].
    Chatal JF, Charbonnel B, Guihard R.
    Nouv Presse Med; 1977 Apr 19; 6(13):1145. PubMed ID: 850632
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Localization of a metastatic adrenal carcinoma using 131-I-19-iodocholesterol.
    Forman BH, Antar MA, Touloukian RJ, Mulrow PJ, Genel M.
    J Nucl Med; 1974 May 19; 15(5):332-4. PubMed ID: 4823265
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adrenal imaging with radioiodocholesterol in the diagnosis of adrenal disorders.
    Anderson BG, Beierwaltes WH.
    Adv Intern Med; 1974 May 19; 19():327-43. PubMed ID: 4815290
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An approach to developing adrenal-gland scanning.
    Nagai T, Solis BA, Koh CS.
    J Nucl Med; 1968 Nov 19; 9(11):576-81. PubMed ID: 5729206
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.